Identifying Glaucoma-Promoting Genes Using Zebrafish
About the Research Project
Program
Award Type
Standard
Award Amount
$90,000
Active Dates
April 01, 2007 - March 31, 2009
Grant ID
G2007046
Acknowledgement
Goals
The main goal of this study is to identify genes that cause ganglion cell degeneration when intraocular pressure (IOP) is elevated, a key feature of many forms of glaucoma. Using zebrafish that show elevated IOP without associated ganglion cell degeneration, we will screen for ‘interacting’ mutations that lead to injury response pathways in retinal ganglion cells and eventually cause blinding degeneration.
Summary
Glaucoma is a leading cause of blindness worldwide and yet our understanding of the genetic basis of this neurodegenerative disease remains largely unknown. One reason for this is that glaucoma is really a collection of diseases and each form is thought to be caused by mutations in multiple genes. Zebrafish are ideal for these studies because they share similar ocular anatomy, physiology and genetics as humans. In addition, zebrafish can be raised in very large numbers at modest cost, facilitating complex forward genetic endeavors. Once the key genes for glaucoma are identified, genetic tests can be developed and ultimately, research for targeted therapies can begin.
Related Grants
National Glaucoma Research
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
National Glaucoma Research
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
National Glaucoma Research
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute